☆ 4.6 Letter

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 96, Issue 4, Pages E95-E98

Publisher

WILEY
DOI: 10.1002/ajh.26084

Keywords

-

Categories

Hematology

Funding

  1. Lymphoma Research Foundation
  2. NIH [R01-CA160979]
  3. Gabrielle's Angel Foundation (New York, NY)
  4. Joan Harris Cancer Foundation (Boston, MA)
  5. Brent Leahey Fund (Dana-Farber Cancer Institute)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.